Skip to main content
. Author manuscript; available in PMC: 2022 Dec 1.
Published in final edited form as: Am J Gastroenterol. 2021 Dec 1;116(12):2446–2454. doi: 10.14309/ajg.0000000000001527

Table 3b:

Rate ratio for time on CFTR modulator versus time not on CFTR modulator among subjects with some CFTR modulator use (n=1,795)

Model Pancreas Sufficient Cystic
Fibrosis (PS-CF)
Pancreas Insufficient Cystic
Fibrosis (PI-CF)
Observed 0.36 (0.13, 1.01), p=0.05 0.53 (0.18, 1.58), p=0.26
Multivariable (adjusted)* 0.36 (0.13, 1.01), p=0.05 0.51 (0.20, 1.30), p=0.16
*

Adjusted for age (continuous)